U.S. Stock News

We'd be surprised if Interface, Inc. ( NASDAQ:TILE ) shareholders haven't noticed that the Chief Commercial Officer...

Anyone interested in Ziff Davis, Inc. ( NASDAQ:ZD ) should probably be aware that the Executive VP, Jeremy Rossen...

We wouldn't blame Sotera Health Company ( NASDAQ:SHC ) shareholders if they were a little worried about the fact that...

Oracle (NYSE:ORCL) expanded its enterprise AI offerings with the launch of an AI powered patient portal in Oracle Health for U.S. customers. The new Oracle Health portal is now generally accessible in the U.S., giving patients AI driven tools for managing health information and care interactions. Oracle introduced new Fusion Agentic Applications and AI agents in its HR suite to bring AI assistants into workforce planning and employee development. The twin launches extend Oracle's use of AI...

National Retail Solutions, a subsidiary of IDT (IDT), has launched direct point-of-sale integration with Uber Eats across the U.S. and Canada. This integration connects NRS retailers to Uber Eats users through real time inventory syncing. See our latest analysis for IDT. IDT’s recent integration news comes as the stock trades at US$65.47, with a 30 day share price return of 6.63% and a 90 day share price return of 23.97%. The 3 year total shareholder return of 174.25% points to strong longer...

Federated Hermes (NYSE:FHI) appointed Edward Lo as head of wholesale business development for Asia ex-Japan, recruited from Baillie Gifford. The firm plans to open a new office in Hong Kong as part of an expanded focus on Asian wholesale clients. The move reshapes regional leadership and is intended to deepen distribution reach and client coverage across key Asian markets. For investors tracking global asset managers expanding across Asia, it can also be worth exploring a wider set of...

In early August 2026, Fidelity National Information Services reported stronger second-quarter and first-half results alongside reaffirmed full-year revenue guidance and a US$0.44 quarterly dividend, while also completing the global rollout of its Digital One Commercial platform into APAC with real-time, multi-rail, multi-currency capabilities. An APAC bank is already using Digital One Commercial on a single instance across 15 countries to serve about 350,000 business customers and over one...

Brookdale Senior Living Inc. reported second-quarter 2026 results showing revenue of US$718.58 million, down from US$812.94 million a year earlier, but moved from a net loss of US$43.02 million to net income of US$23.27 million, with basic and diluted earnings per share from continuing operations improving from a loss of US$0.18 to earnings of US$0.10. Despite weaker top-line performance over both the quarter and first half, Brookdale returned to profitability, strengthened its balance sheet...

In the past quarter, Frontier Group Holdings reported second quarter 2026 revenue of US$1,279 million, up from US$929 million a year earlier, alongside a wider net loss of US$90 million versus US$70 million previously. The combination of strong top-line growth and deeper losses highlights how cost pressures or operational issues are offsetting Frontier’s growing passenger revenue base. Next, we’ll examine how Frontier’s higher revenue but expanding net loss shapes its existing investment...

Cooling US inflation, a more cautious Federal Reserve stance and relief on tariffs are quietly reshaping the outlook for value focused consumer and discount retailers. This mix of softer price pressures and potential margin relief could change how investors think about steady, cash generating US retailers exposed to these trends. This article walks through three stocks from our screener that appear positively exposed to this news backdrop and explains what investors should watch. The three...

THOR Industries has faced several years of pressure, with annual sales falling around 2.3% and earnings per share dropping even faster, pointing to weaker profitability per unit sold. Returns on capital have also compressed, suggesting that the company’s earlier high-margin opportunities are harder to replicate and its existing profit engines are losing efficiency. Next, we will examine how these ongoing profitability challenges and weakening returns on capital influence THOR Industries’...

ADMA Biologics recently reported its second-quarter 2026 results, with sales of US$124.4 million and net income of US$37.82 million, and it reaffirmed full-year revenue guidance of US$530 million to US$560 million. The combination of higher quarterly and year-to-date earnings per share versus last year and maintained revenue expectations highlights management’s confidence in the company’s current operating trajectory. Next, we’ll consider how ADMA’s reaffirmed 2026 revenue guidance could...

Vornado Realty Trust (NYSE:VNO) has entered a joint venture with Rudin Management and an affiliate of Kenneth Griffin for a new office project at 350 Park Avenue in Manhattan. The partnership plans a 1.9 million sq ft office development on Park Avenue, centered on a landmark property in Midtown. The deal formalizes Vornado's role alongside major partners and reflects a significant capital commitment to a high profile New York office asset. The project is expected to influence Vornado's long...

Taysha Gene Therapies stock has delivered a very strong 231.9% return over the past three years, yet current valuation checks and market multiples point to a less straightforward picture of whether the recent gains leave enough room for upside from here. The stock is up 231.9% over three years, which puts extra weight on whether recent optimism about its gene therapy pipeline is already reflected in the share price. Progress on TSHA-102 for Rett syndrome, including completed dosing in key...

IDEXX Laboratories has had a weak run over the past five years, yet the current checks suggest the stock is not obviously cheap, with the Discounted Cash Flow (DCF) estimate pointing to a price close to intrinsic value while market multiples lean expensive. That mix leaves investors weighing a fairly valued intrinsic view against richer headline valuation ratios. IDEXX Laboratories has delivered a decline of 15.7% over five years, which softens the long term return story even before looking...

People (PPLI) is in focus after its second quarter results showed higher profitability alongside modestly lower sales, with investors also weighing fresh 2026 guidance, new leadership appointments and ongoing interest in its digital and AI initiatives. See our latest analysis for People. Despite the strong Q2 profit figures and leadership updates, People’s 30 day share price return is down 11.55%, while the 1 year total shareholder return of 13.95% points to longer term momentum that is still...

In August 2026, Helios Technologies, Inc. reported second-quarter sales of US$231.9 million and net income of US$21.9 million, then raised its full-year 2026 sales guidance to a range of US$880 million to US$900 million alongside new third-quarter sales guidance of US$215 million to US$222 million. Management also declared its two-year business stabilization plan complete, signaling a shift to a “takeoff” phase that includes targeting data center thermal management as a major growth...

Global Payments Inc. reported past second-quarter 2026 results showing sales of US$3,320.79 million but net income of just US$12.97 million, alongside sharply lower earnings per share compared with a year earlier. Despite the weaker profitability and a net loss of about US$1.79 billion over the first half of 2026, the board still approved a US$0.25 per share dividend payable on September 25, 2026, underscoring a commitment to ongoing shareholder payouts. Next, we’ll examine how the weaker...

Why Oppenheimer Holdings Stock Is Back in Focus After Q2 Results Oppenheimer Holdings (OPY) moved back onto investor watchlists after reporting second quarter 2026 earnings that showed higher revenue and net income versus a year earlier, alongside an affirmed quarterly dividend. See our latest analysis for Oppenheimer Holdings. The 1 day share price return of 1.47% to US$114.81 came after Oppenheimer Holdings reported higher second quarter revenue and earnings. This follows a 90 day share...

In August 2026, Valvoline Inc. reported its third-quarter results, with sales rising to US$544.6 million and net income reaching US$64.5 million, while also posting higher basic and diluted earnings per share from continuing operations than a year earlier. Despite stronger third-quarter performance, the company’s net income for the first nine months fell to US$76.5 million even as sales increased to US$1.51 billion, highlighting a contrast between recent quarterly momentum and weaker...

Invesco stock has delivered a strong 133.2% return over the past three years, while the intrinsic value estimate from the Excess Returns model points to upside and the market multiple view suggests the shares trade on the expensive side. That split leaves investors weighing a mixed valuation picture rather than a clear bargain or obvious overpricing. Over the past three years, Invesco has returned 133.2%, which puts recent gains at the center of any valuation call on the stock. Expectations...

In August 2026, Alpha Metallurgical Resources, Inc. reported second-quarter 2026 results showing revenue of US$492.86 million, down from US$550.27 million a year earlier, and a net loss of US$12.25 million versus US$4.95 million, with basic and diluted loss per share from continuing operations widening to US$0.96 from US$0.38. For the first half of 2026, however, revenue declined modestly to US$1,017.84 million from US$1,082.23 million while the net loss narrowed to US$23.28 million from...

Smithfield Foods stock has fallen around 9.9% over the past week, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples still point to the shares trading below what the fundamentals suggest. The share price declined about 9.9% over the last seven days, which has made the recent valuation gap to intrinsic value more pronounced. The key upside driver is the market's view on Smithfield Foods' ability to keep converting revenue into reliable cash flows. Any...

Dianthus Therapeutics (DNTH) has drawn fresh attention after reporting a second quarter net loss of US$50.22 million and unveiling DNTH312, a first in class bifunctional fusion protein targeting autoimmune disease pathways. See our latest analysis for Dianthus Therapeutics. The latest DNTH312 announcement and second quarter update come after a period of strong momentum in Dianthus Therapeutics’ stock, with a 30 day share price return of 13.96% and a 90 day share price return of 31.72%. The...